Similarly, the almost ubiquitous abundance of SOX2 within GBM suggests that this marker is expressed on the more differentiated cells reflecting SOX2 as a putative progenitor cell marker within the GBM samples used in this study. The gene discussed is SOX2; the disease is glioblastoma.